BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23673142)

  • 41. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes.
    Parratt JD; Prineas JW
    Mult Scler; 2010 Oct; 16(10):1156-72. PubMed ID: 20823059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aquaporin 4 expression and tissue susceptibility to neuromyelitis optica.
    Matiello M; Schaefer-Klein J; Sun D; Weinshenker BG
    JAMA Neurol; 2013 Sep; 70(9):1118-25. PubMed ID: 23857303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and treatment of neuromyelitis optica.
    Wingerchuk DM
    Neurologist; 2007 Jan; 13(1):2-11. PubMed ID: 17215722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics.
    Kim SM; Go MJ; Sung JJ; Park KS; Lee KW
    Arch Neurol; 2012 Aug; 69(8):1026-31. PubMed ID: 22473770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The clinical characteristics of primary Sjögren syndrome with neuromyelitis optica].
    Qiao L; Luo Y; Zhang LL; Zhao LD; Wang Q; Xu Y; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):745-8. PubMed ID: 24314164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuromyelitis optica: new findings on pathogenesis.
    Wingerchuk DM
    Int Rev Neurobiol; 2007; 79():665-88. PubMed ID: 17531863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.
    Warabi Y; Matsumoto Y; Hayashi H
    J Neurol Sci; 2007 Jan; 252(1):57-61. PubMed ID: 17125797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined brain and anterior visual pathways' MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis.
    Buch D; Savatovsky J; Gout O; Vignal C; Deschamps R
    Acta Neurol Belg; 2017 Mar; 117(1):67-74. PubMed ID: 27804015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ocular oscillations in the neuromyelitis optica spectrum.
    Hage R; Merle H; Jeannin S; Cabre P
    J Neuroophthalmol; 2011 Sep; 31(3):255-9. PubMed ID: 21623230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive functions in neuromyelitis optica.
    Blanc F; Zéphir H; Lebrun C; Labauge P; Castelnovo G; Fleury M; Sellal F; Tranchant C; Dujardin K; Vermersch P; de Seze J
    Arch Neurol; 2008 Jan; 65(1):84-8. PubMed ID: 18195143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optic neuritis: experience from a south Indian demyelinating disease registry.
    Pandit L; Shetty R; Misri Z; Bhat S; Amin H; Pai V; Rao R
    Neurol India; 2012; 60(5):470-5. PubMed ID: 23135022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spectrum of pediatric neuromyelitis optica.
    Lotze TE; Northrop JL; Hutton GJ; Ross B; Schiffman JS; Hunter JV
    Pediatrics; 2008 Nov; 122(5):e1039-47. PubMed ID: 18838462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome.
    Mehta LR; Samuelsson MK; Kleiner AK; Goodman AD; Anolik JH; Looney RJ; Schwid SR
    Mult Scler; 2008 Apr; 14(3):425-7. PubMed ID: 18208886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuromyelitis optica IgG status in acute partial transverse myelitis.
    Scott TF; Kassab SL; Pittock SJ
    Arch Neurol; 2006 Oct; 63(10):1398-400. PubMed ID: 17030654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seropositive neuromyelitis optica: a pediatric case report and 6-year follow-up.
    Maraş H; Kara B; Anık Y
    Pediatr Neurol; 2013 Sep; 49(3):198-202. PubMed ID: 23831249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.
    Argyriou AA; Makris N
    Acta Neurol Scand; 2008 Oct; 118(4):209-17. PubMed ID: 18336627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropathic pruritus (itch) in neuromyelitis optica.
    Elsone L; Townsend T; Mutch K; Das K; Boggild M; Nurmikko T; Jacob A
    Mult Scler; 2013 Apr; 19(4):475-9. PubMed ID: 22936333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach.
    Pichiecchio A; Tavazzi E; Poloni G; Ponzio M; Palesi F; Pasin M; Piccolo L; Tosello D; Romani A; Bergamaschi R; Piccolo G; Bastianello S
    Mult Scler; 2012 Jun; 18(6):817-24. PubMed ID: 22183930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.